Acadian Asset Management
ACET icon

Acadian Asset Management’s Adicet Bio ACET Stock Holding History

Acadian Asset Management’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.08M Buy
124,832
+6,694
+6% +$52.8K ﹤0.01% 1244
2026
Q1 		$802K Sell
118,138
-63,257
-35% -$473K ﹤0.01% 1230
2025
Q4 		$1.52M Buy
181,395
+39,802
+28% +$440K ﹤0.01% 991
2025
Q3 		$1.83M Buy
141,593
+11,930
+9% +$141K ﹤0.01% 910
2025
Q2 		$1.26M Buy
129,663
+2,205
+2% +$23.3K ﹤0.01% 936
2025
Q1 		$1.54M Buy
127,458
+2,268
+2% +$32.4K ﹤0.01% 826
2024
Q4 		$1.93M Buy
125,190
+7,694
+7% +$145K 0.01% 774
2024
Q3 		$2.71M Buy
117,496
+49,678
+73% +$1.11M 0.01% 660
2024
Q2 		$1.31M Buy
67,818
+45,609
+205% +$1.22M ﹤0.01% 904
2024
Q1 		$834K Sell
22,209
-12,775
-37% -$528K ﹤0.01% 891
2023
Q4 		$1.06M Buy
34,984
+2,296
+7% +$50.1K ﹤0.01% 844
2023
Q3 		$715K Buy
32,688
+31,256
+2,183% +$1.1M ﹤0.01% 931
2023
Q2 		$54K Buy
+1,432
New +$126K ﹤0.01% 1514
2021
Q3 		– Sell
-303
Closed -$50K – 1689
2021
Q2 		$50K Sell
303
-2,286
-88% -$466K ﹤0.01% 1797
2021
Q1 		$542K Sell
2,589
-219
-8% -$50.3K ﹤0.01% 1164
2020
Q4 		$632K Sell
2,808
-3,890
-58% -$797K ﹤0.01% 1151
2020
Q3 		$1.27M Sell
6,698
-1,289
-16% -$326K 0.01% 814
2020
Q2 		$1.92M Sell
7,987
-423
-5% -$83.1K 0.01% 751
2020
Q1 		$970K Buy
8,410
+4,320
+106% +$641K 0.01% 800
2019
Q4 		$683K Buy
+4,090
New +$2.07M ﹤0.01% 991

Other funds holding ACET

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

Acadian Asset Management's ACET Position: Q2 2026 in Review

Acadian Asset Management increased its Adicet Bio (ACET) stake by 5.7% in Q2 2026, buying an estimated $52.8K and bringing the position to 124,832 shares worth $1.08M. The position accounts for ﹤0.01% of the portfolio, ranked #1244.

Acadian Asset Management first reported a position in ACET in Q4 2019 and has held it in 20 quarters since. The position peaked at $2.71M in Q3 2024. 56 funds tracked by Wall St. Rank hold ACET as of Q2 2026.

  • Acadian Asset Management held 124,832 shares of Adicet Bio worth $1.08M as of Q2 2026.
  • Acadian Asset Management bought 6,694 Adicet Bio shares in Q2 2026, an estimated $52.8K.
  • Adicet Bio made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1244 holding.
  • Acadian Asset Management first reported a position in Adicet Bio in Q4 2019 and has held it in 20 quarters since.
  • Acadian Asset Management's Adicet Bio position peaked at $2.71M in Q3 2024.
  • 56 funds tracked by Wall St. Rank held Adicet Bio as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.